Latest News

Use of tPA for ischemic stroke nearly doubled from 2003 to 2011

Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. A research team reports both an overall increase in the use of tPA to dissolve clots blocking arteries supplying the brain and administration of the potentially life-saving drug to a more diverse group of patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Forget about the car keys, do you know when to take away your parent's checkbook?

  • Follow-up on psychiatric disorders in young people after release from detention

  • Teens with a history of TBI are nearly 4 times more likely to have used crystal meth

  • Stroke damage mechanism identified

  • Drug to reduce side-effects of 'binge drinking' developed

  • How do Tourette's patients react to visual stimulation with their own self-image?

  • 'Trigger' for stress processes discovered in brain

  • New research supporting stroke rehabilitation

  • Mindfulness treatment as effective as CBT for depression, anxiety

  • Fragile X study offers hope of new autism treatment

  •